Company intelligence / Profile preview
Otsuka Holdings
Tokyo, Tokyo, Japan
- Ownership
- Public · 4578
- Employees
- ~45000
- Development stage
- Other
01
Overview
Otsuka Holdings is a leading Japanese pharmaceutical and nutraceutical conglomerate with global reach and a robust clinical pipeline encompassing CNS, nephrology, oncology, immunology, and rare diseases. Its flagship drugs such as aripiprazole (Abilify), tolvaptan, and lonsurf are commercialized worldwide, with ongoing late-stage programs in IgA nephropathy, chronic kidney disease, and rare CNS/immune disorders. Several antibody, small molecule, and diagnostic assets are in clinical and earlier development.[2][4][6][8]
- Therapeutic areas
- ImmunologyNephrologyMetabolic DisordersPsychiatryInfectious DiseasesDermatologyPulmonologyCardiovascularOncologyNeurology
- Modalities
- Small moleculeMonoclonal antibodyAntisense oligonucleotideGene panel diagnosticsBiologicVaccinePeptides
- Industry
- Pharma
02
Drug pipeline
54 assets53 more assets in the full pipeline.
Request access →03
Partnerships
LundbeckAkebiaMeijiVisterraSumitomo PharmaIonis PharmaceuticalsBill & Melinda Gates Foundation
Beyond the preview
Go deeper on Otsuka Holdings.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Otsuka Holdings.